Your session is about to expire
← Back to Search
Saskatoon Berry for Metabolism Enhancement
N/A
Recruiting
Led By Garry Shen, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up onset and 10 weeks after the start of dietary intervention
Awards & highlights
Summary
This trial will examine the effect of Saskatoon berry on glucose metabolism, insulin resistance, and gut microbiota in healthy adults.
Who is the study for?
This trial is for healthy individuals living in Winnipeg who are willing to sign an informed consent. It's not open to those taking hypoglycemic, anti-hypertensive or lipid-lowering medications, antibiotics within the last month, or with a history of serious metabolic diseases.
What is being tested?
The study investigates the effects of freeze-dried Saskatoon berry on glucose metabolism, insulin resistance and gut microbiota in healthy adults. This pilot trial aims to explore if this berry can help manage or prevent type 2 diabetes and metabolic syndrome.
What are the potential side effects?
Since Saskatoon berries are natural foods, they may be safer than conventional hypoglycemic medications. However, potential side effects aren't detailed here; typically these could include digestive discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ changes from baseline to 10 weeks after the start of dietary intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes from baseline to 10 weeks after the start of dietary intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Glucose tolerance
Gut microbiome
Secondary study objectives
Blood pressure
Body mass index accord to body weight and height
C-reactive protein
+3 moreOther study objectives
Dietary intake, physical activities
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Single arm
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
612 Previous Clinical Trials
201,534 Total Patients Enrolled
Diabetes CanadaOTHER
10 Previous Clinical Trials
1,087 Total Patients Enrolled
Garry Shen, PhDPrincipal InvestigatorUniversity of Manitoba
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of heart attack, stroke, high blood pressure, diabetes, high cholesterol, or kidney disease.I have been taking medication for diabetes, high blood pressure, cholesterol, or antibiotics in the last month.
Research Study Groups:
This trial has the following groups:- Group 1: Single arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger